27501363|t|Amyloid beta attenuates metabotropic zinc sensing receptor, mZnR/GPR39, dependent Ca2+ , ERK1/2 and Clusterin signaling in neurons.
27501363|a|A hallmark of Alzheimer's disease is accumulation of amyloid beta (Abeta) deposits, which are associated with neuronal dysfunction, spine loss, and impaired Ca2+ homeostasis. Amyloid beta (Abeta) binds to and is aggregated by Zn2+ , a metal released from synaptic glutamatergic vesicles during neuronal activity. Synaptically released Zn2+ activates a metabotropic Gq-coupled Zn2+ -sensing receptor, mZnR/GPR39, and induces Ca2+ -signaling in post-synaptic neurons. We examined if Abeta, as a Zn2+ binding protein, regulates neuronal Zn2+ -signaling mediated by mZnR/GPR39 using SHSY-5Y cells and cortical neurons from GPR39 wild-type and knockout mice. Following acute or chronic treatment with Abeta neuronal Zn2+ -dependent Ca2+ release via mZnR/GPR39 is significantly reduced. This impairment is overcome when excess Zn2+ is applied, suggesting that impaired Ca2+ -signaling results from Abeta binding of Zn2+ . The Zn2+ -dependent mZnR/GPR39 activation triggers phosphorylation of extracellular regulated kinase and up-regulates expression of the chaperone protein clusterin (Clu). Importantly, neuronal Zn2+ -dependent extracellular regulated kinase1/2 phosphorylation and up-regulation of Clu are attenuated by silencing mZnR/GPR39 as well as by Abeta treatment. In contrast, Zn2+ -dependent AKT phosphorylation is not mediated by mZnR/GPR39 and is not attenuated by Abeta treatment. Thus, Zn2+ signaling via mZnR/GPR39 is distinctively disrupted by a critical pathological component of Alzheimer's disease. Synaptically released Zn2+ activates a Zn2+ -sensing receptor, mZnR/GPR39, and induces Ca2+ -signaling, followed by ERK1/2 MAPK activation and up-regulation of clusterin. Amyloid beta (Abeta) binds to Zn2+ thus forming oligomers that are a hallmark of Alzheimer's disease. We show that Abeta attenuates Zn2+ -dependent Ca2+ -responses, abolishes ERK1/2 activation and down-regulates clusterin expression. Thus, Zn2+ signaling via mZnR/GPR39 is disrupted by Abeta, a critical pathological component of Alzheimer's disease.
27501363	65	70	GPR39	Gene	2863
27501363	82	86	Ca2+	Chemical	-
27501363	89	95	ERK1/2	Gene	5595;5594
27501363	100	109	Clusterin	Gene	12759
27501363	146	165	Alzheimer's disease	Disease	MESH:D000544
27501363	199	204	Abeta	Gene	11820
27501363	242	262	neuronal dysfunction	Disease	MESH:D009461
27501363	264	274	spine loss	Disease	MESH:D016135
27501363	289	293	Ca2+	Chemical	-
27501363	321	326	Abeta	Gene	11820
27501363	358	362	Zn2+	Chemical	-
27501363	467	471	Zn2+	Chemical	-
27501363	537	542	GPR39	Gene	2863
27501363	556	560	Ca2+	Chemical	-
27501363	613	618	Abeta	Gene	11820
27501363	625	645	Zn2+ binding protein	Chemical	-
27501363	666	670	Zn2+	Chemical	-
27501363	699	704	GPR39	Gene	71111
27501363	711	718	SHSY-5Y	CellLine	CVCL:0019
27501363	751	756	GPR39	Gene	71111
27501363	780	784	mice	Species	10090
27501363	828	833	Abeta	Gene	11820
27501363	843	847	Zn2+	Chemical	-
27501363	859	863	Ca2+	Chemical	-
27501363	881	886	GPR39	Gene	2863
27501363	953	957	Zn2+	Chemical	-
27501363	995	999	Ca2+	Chemical	-
27501363	1024	1029	Abeta	Gene	11820
27501363	1041	1045	Zn2+	Chemical	-
27501363	1052	1056	Zn2+	Chemical	-
27501363	1073	1078	GPR39	Gene	2863
27501363	1202	1211	clusterin	Gene	1191
27501363	1213	1216	Clu	Gene	1191
27501363	1328	1331	Clu	Gene	1191
27501363	1365	1370	GPR39	Gene	2863
27501363	1385	1390	Abeta	Gene	11820
27501363	1415	1419	Zn2+	Chemical	-
27501363	1431	1434	AKT	Gene	207
27501363	1475	1480	GPR39	Gene	71111
27501363	1506	1511	Abeta	Gene	11820
27501363	1529	1533	Zn2+	Chemical	-
27501363	1553	1558	GPR39	Gene	71111
27501363	1626	1645	Alzheimer's disease	Disease	MESH:D000544
27501363	1669	1673	Zn2+	Chemical	-
27501363	1715	1720	GPR39	Gene	2863
27501363	1734	1738	Ca2+	Chemical	-
27501363	1763	1769	ERK1/2	Gene	5595;5594
27501363	1807	1816	clusterin	Gene	1191
27501363	1832	1837	Abeta	Gene	11820
27501363	1848	1852	Zn2+	Chemical	-
27501363	1899	1918	Alzheimer's disease	Disease	MESH:D000544
27501363	1933	1938	Abeta	Gene	351
27501363	1950	1954	Zn2+	Chemical	-
27501363	1966	1970	Ca2+	Chemical	-
27501363	1993	1999	ERK1/2	Gene	5595;5594
27501363	2030	2039	clusterin	Gene	1191
27501363	2058	2062	Zn2+	Chemical	-
27501363	2082	2087	GPR39	Gene	2863
27501363	2104	2109	Abeta	Gene	351
27501363	2148	2167	Alzheimer's disease	Disease	MESH:D000544
27501363	Negative_Correlation	1191	351
27501363	Positive_Correlation	MESH:D016135	11820
27501363	Negative_Correlation	351	5594
27501363	Association	2863	5594
27501363	Association	MESH:D000544	11820
27501363	Association	MESH:D000544	71111
27501363	Positive_Correlation	1191	2863
27501363	Negative_Correlation	11820	1191
27501363	Positive_Correlation	11820	2863
27501363	Negative_Correlation	351	5595
27501363	Association	2863	5595
27501363	Association	MESH:D009461	11820
27501363	Association	12759	2863

